Polysorbate 80 add-on therapy in the treatment of Helicobacter pylori infection: Polysorbate 80 and HP antibiotic resistance

Michele Di Stefano, Elisabetta Pagani, Eugenia Vittoria Pesatori, Manuela Bergonzi, Natale Figura, Gino Roberto Corazza, Antonio Di Sabatino

Research output: Contribution to journalArticle

Abstract

Polysorbate 80, a sorbitan derivate, is a surfactant used as an emulsifier in some foods in concentrations of up to 0.5%. It was recently shown in vitro that polysorbate 80 decreases the minimum bactericidal concentrations of clarithromycin and metronidazole and may also revert antibiotic resistance. We report the case of an adult man, suffering from symptomatic Helicobacter pylori (HP) infection resistant to two courses of treatment with PPI plus amoxicillin and clarithromycin, and PPI plus clarithromycin and metronidazole. He was treated with a further antibiotic approach consisting of two-week administration of clarithromycin, metronidazole, PPI and polysorbate 80 as an add on therapy. Eradication of infection was confirmed by 13C-urea breath test two and five months after completion of the treatment course. Complete regression of symptoms was also achieved. To our knowledge, this is the first case of HP infection eradicated with a combination therapy based on polysorbate 80 added to antibiotics.

Original languageEnglish
JournalClinical Nutrition ESPEN
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Clarithromycin
Polysorbates
Helicobacter Infections
Microbial Drug Resistance
Helicobacter pylori
Metronidazole
Anti-Bacterial Agents
Breath Tests
Amoxicillin
Therapeutics
Surface-Active Agents
Urea
Food
Infection

Keywords

  • Antibiotic resistance
  • Helicobacter pylori
  • Polysorbate 80
  • Resistant HP infection
  • Tween 80

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Polysorbate 80 add-on therapy in the treatment of Helicobacter pylori infection : Polysorbate 80 and HP antibiotic resistance. / Di Stefano, Michele; Pagani, Elisabetta; Pesatori, Eugenia Vittoria; Bergonzi, Manuela; Figura, Natale; Corazza, Gino Roberto; Di Sabatino, Antonio.

In: Clinical Nutrition ESPEN, 01.01.2019.

Research output: Contribution to journalArticle

@article{e163fcd63d9c4e05bb445f999b4f1896,
title = "Polysorbate 80 add-on therapy in the treatment of Helicobacter pylori infection: Polysorbate 80 and HP antibiotic resistance",
abstract = "Polysorbate 80, a sorbitan derivate, is a surfactant used as an emulsifier in some foods in concentrations of up to 0.5{\%}. It was recently shown in vitro that polysorbate 80 decreases the minimum bactericidal concentrations of clarithromycin and metronidazole and may also revert antibiotic resistance. We report the case of an adult man, suffering from symptomatic Helicobacter pylori (HP) infection resistant to two courses of treatment with PPI plus amoxicillin and clarithromycin, and PPI plus clarithromycin and metronidazole. He was treated with a further antibiotic approach consisting of two-week administration of clarithromycin, metronidazole, PPI and polysorbate 80 as an add on therapy. Eradication of infection was confirmed by 13C-urea breath test two and five months after completion of the treatment course. Complete regression of symptoms was also achieved. To our knowledge, this is the first case of HP infection eradicated with a combination therapy based on polysorbate 80 added to antibiotics.",
keywords = "Antibiotic resistance, Helicobacter pylori, Polysorbate 80, Resistant HP infection, Tween 80",
author = "{Di Stefano}, Michele and Elisabetta Pagani and Pesatori, {Eugenia Vittoria} and Manuela Bergonzi and Natale Figura and Corazza, {Gino Roberto} and {Di Sabatino}, Antonio",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.clnesp.2019.08.005",
language = "English",
journal = "Clinical Nutrition ESPEN",
issn = "2405-4577",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Polysorbate 80 add-on therapy in the treatment of Helicobacter pylori infection

T2 - Polysorbate 80 and HP antibiotic resistance

AU - Di Stefano, Michele

AU - Pagani, Elisabetta

AU - Pesatori, Eugenia Vittoria

AU - Bergonzi, Manuela

AU - Figura, Natale

AU - Corazza, Gino Roberto

AU - Di Sabatino, Antonio

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Polysorbate 80, a sorbitan derivate, is a surfactant used as an emulsifier in some foods in concentrations of up to 0.5%. It was recently shown in vitro that polysorbate 80 decreases the minimum bactericidal concentrations of clarithromycin and metronidazole and may also revert antibiotic resistance. We report the case of an adult man, suffering from symptomatic Helicobacter pylori (HP) infection resistant to two courses of treatment with PPI plus amoxicillin and clarithromycin, and PPI plus clarithromycin and metronidazole. He was treated with a further antibiotic approach consisting of two-week administration of clarithromycin, metronidazole, PPI and polysorbate 80 as an add on therapy. Eradication of infection was confirmed by 13C-urea breath test two and five months after completion of the treatment course. Complete regression of symptoms was also achieved. To our knowledge, this is the first case of HP infection eradicated with a combination therapy based on polysorbate 80 added to antibiotics.

AB - Polysorbate 80, a sorbitan derivate, is a surfactant used as an emulsifier in some foods in concentrations of up to 0.5%. It was recently shown in vitro that polysorbate 80 decreases the minimum bactericidal concentrations of clarithromycin and metronidazole and may also revert antibiotic resistance. We report the case of an adult man, suffering from symptomatic Helicobacter pylori (HP) infection resistant to two courses of treatment with PPI plus amoxicillin and clarithromycin, and PPI plus clarithromycin and metronidazole. He was treated with a further antibiotic approach consisting of two-week administration of clarithromycin, metronidazole, PPI and polysorbate 80 as an add on therapy. Eradication of infection was confirmed by 13C-urea breath test two and five months after completion of the treatment course. Complete regression of symptoms was also achieved. To our knowledge, this is the first case of HP infection eradicated with a combination therapy based on polysorbate 80 added to antibiotics.

KW - Antibiotic resistance

KW - Helicobacter pylori

KW - Polysorbate 80

KW - Resistant HP infection

KW - Tween 80

UR - http://www.scopus.com/inward/record.url?scp=85070676458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070676458&partnerID=8YFLogxK

U2 - 10.1016/j.clnesp.2019.08.005

DO - 10.1016/j.clnesp.2019.08.005

M3 - Article

AN - SCOPUS:85070676458

JO - Clinical Nutrition ESPEN

JF - Clinical Nutrition ESPEN

SN - 2405-4577

ER -